New members
Biotechnology Research
2024 FAB Award Winner - Life Sciences Large Company
TreeFrog Therapeutics is a French-based biotech company set to unlock access to cell therapies for millions of patients. TreeFrog is unique in its approach to cell therapy development bringing together biophysicists, cell biologists, and bioproduction engineers to address the challenges of the industry – producing and differentiating cells of quality at unprecedented scale, cost-effectively. To realize their mission of Cell Therapy for all, TreeFrog operates a hybrid business model that includes its own therapeutic programs and partnerships with leading biotech and industry players in other areas. This year, they signed a $750M agreement with Vertex. In the last 3 years, the company has raised $82 million to advance a pipeline of stem cell-based therapies in regenerative medicine with a lead program in Parkinson’s disease.
